AU2003225191A1 - Methods useful in treatment and prevention of hiv infection - Google Patents

Methods useful in treatment and prevention of hiv infection

Info

Publication number
AU2003225191A1
AU2003225191A1 AU2003225191A AU2003225191A AU2003225191A1 AU 2003225191 A1 AU2003225191 A1 AU 2003225191A1 AU 2003225191 A AU2003225191 A AU 2003225191A AU 2003225191 A AU2003225191 A AU 2003225191A AU 2003225191 A1 AU2003225191 A1 AU 2003225191A1
Authority
AU
Australia
Prior art keywords
prevention
treatment
hiv infection
methods useful
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003225191A
Other versions
AU2003225191A8 (en
Inventor
Ali Amara
Fernando Arenzana-Seisdedos
Serge J. E. Lebecque
Jean-Jacques Pin
Sem Saeland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU2003225191A1 publication Critical patent/AU2003225191A1/en
Publication of AU2003225191A8 publication Critical patent/AU2003225191A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2851—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003225191A 2002-05-02 2003-04-30 Methods useful in treatment and prevention of hiv infection Abandoned AU2003225191A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37745902P 2002-05-02 2002-05-02
US60/377,459 2002-05-02
PCT/US2003/013163 WO2003093415A2 (en) 2002-05-02 2003-04-30 Methods useful in treatment and prevention of hiv infection

Publications (2)

Publication Number Publication Date
AU2003225191A1 true AU2003225191A1 (en) 2003-11-17
AU2003225191A8 AU2003225191A8 (en) 2003-11-17

Family

ID=29401501

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003225191A Abandoned AU2003225191A1 (en) 2002-05-02 2003-04-30 Methods useful in treatment and prevention of hiv infection

Country Status (2)

Country Link
AU (1) AU2003225191A1 (en)
WO (1) WO2003093415A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200371110A1 (en) * 2018-01-12 2020-11-26 The Wistar Institute Of Anatomy And Biology Methods for identifying and treating hiv persistence

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0997476A3 (en) * 1998-09-25 2000-07-19 Schering-Plough Antibodies to a mammalian Langerhans cell antigen and their uses

Also Published As

Publication number Publication date
WO2003093415A2 (en) 2003-11-13
WO2003093415A3 (en) 2004-02-26
AU2003225191A8 (en) 2003-11-17

Similar Documents

Publication Publication Date Title
AU2003290548A1 (en) Prevention and treatment of synucleinopathic disease
AU2003260527A1 (en) Methods of positions and/or orienting nanostructures
AU2003257937A1 (en) Methods and compositions for treatment of dermal conditions
AU2003291342A1 (en) Benzotriazoles and methods of prophylaxis or treatment of metabolic-related disorders thereof
AU2001243219A1 (en) Methods of prevention and treatment of asthma, and allergic conditions
AU2003209851A1 (en) Method of treatment and/or prophylaxis
AU2002356868A1 (en) Methods for the prevention or treatment of bacterial and fungal infections
AU2002323270A1 (en) Composition and method for treating hiv infection
AUPQ622600A0 (en) Treatment and/or prevention of ocular pain
AU2002219881A1 (en) Methods and compositions for the treatment of human immunodeficiency virus infection
AU2002220257A1 (en) Methods of treatment involving human mda-7
AU2003274963A1 (en) Mda-7 and free radicals in the treatment of cancer
AU2003217604A1 (en) Method of treating hiv infection by preventing interaction of cd4 and gp120
AU2003259202A1 (en) Compositions and methods for treating and preventing infection
AU2002365168A1 (en) Method and composition for treating and preventing hiv infection and aids
AU2003287802A1 (en) Palpometer and methods of use thereof
AU2003213898A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU2003225191A1 (en) Methods useful in treatment and prevention of hiv infection
AU2003244455A1 (en) Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
AU2001267165A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU2003238175A1 (en) Treatment of serious infections and septic shock
AU2002222125A1 (en) Prevention and treatment of tachyphylactic response
AU2002355578A1 (en) Thermostable uvra and uvrb polipeptides and methods of use
AU2002360523A1 (en) Compounds to treat hiv infection and aids
AU2002241162A1 (en) Intimins in the prevention or treatment of infections:ii

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase